Retour
Fourchette du Jour
3,86 €
4,10 €
Fourchette 52 Semaines
3,20 €
6,99 €
Volume
1 200
Moyenne 50J / 200J
4,29 €
/
4,91 €
Clôture Précédente
3,86 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 49,7 | 0,3 |
| P/B | 0,3 | 2,9 |
| ROE % | 0,5 | 3,7 |
| Net Margin % | 2,6 | 3,8 |
| Rev Growth 5Y % | -29,9 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
3,00 €
2,87 € – 3,14 €
|
2,6 B | 1 |
| FY2027 |
1,62 €
1,54 € – 1,69 €
|
1,8 B | 1 |
| FY2026 |
0,98 €
0,93 € – 1,02 €
|
1,5 B | 1 |
Points Clés
Revenue declined -29,86% annually over 5 years
ROE of 0,53% is below average
Debt/Equity of 0,41 — conservative balance sheet
Negative free cash flow of -626,43M
P/E of 49,66 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 55,98%
Croissance
Revenue Growth (5Y)
-29,86%
Revenue (1Y)26,12%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
0,53%
ROIC0,25%
Net Margin2,61%
Op. Margin2,24%
Sécurité
Debt / Equity
0,41
Current Ratio2,42
Interest Coverage0,00
Valorisation
P/E Ratio
49,66
P/B Ratio0,27
EV/EBITDA77,49
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26,12% | Revenue Growth (3Y) | 73,61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -29,86% | Earnings Growth (5Y) | -65,49% |
| Profitability | |||
| Revenue (TTM) | 1,04B | Net Income (TTM) | 27,15M |
| ROE | 0,53% | ROA | 0,34% |
| Gross Margin | 0,00% | Operating Margin | 2,24% |
| Net Margin | 2,61% | Free Cash Flow (TTM) | -626,43M |
| ROIC | 0,25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,41 | Current Ratio | 2,42 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 49,66 | P/B Ratio | 0,27 |
| P/S Ratio | 1,30 | PEG Ratio | -2,89 |
| EV/EBITDA | 77,49 | Dividend Yield | 0,00% |
| Market Cap | 1,35B | Enterprise Value | 1,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,04B | 824,88M | 345,18M | 1,03B | 4,30B |
| Net Income | 27,15M | -378,88M | -1,48B | -909,43M | 1,91B |
| EPS (Diluted) | 0,11 | -1,53 | -6,01 | -3,69 | 7,74 |
| Gross Profit | 0,0 | 580,45M | -876,02M | -186,61M | 3,00B |
| Operating Income | 23,30M | -403,39M | -2,04B | -1,37B | 1,94B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7,96B | 9,32B | 11,47B | 11,87B | 6,75B |
| Total Liabilities | 3,05B | 4,03B | 4,22B | 3,33B | 677,22M |
| Shareholders' Equity | 4,91B | 5,27B | 6,75B | 8,00B | 6,07B |
| Total Debt | 2,01B | 2,70B | 2,70B | 1,37B | 142,54M |
| Cash & Equivalents | 1,56B | 2,05B | 3,39B | 5,46B | 4,45B |
| Current Assets | 4,28B | 5,18B | 7,73B | 9,29B | 5,42B |
| Current Liabilities | 1,77B | 2,59B | 2,94B | 2,87B | 412,85M |